n (%) | |
---|---|
Median age, years (range) | 61 (39.5-73.8) |
35–49 years | 10 (14.3%) |
50–64 years | 36 (51.4%) |
≥ 65 years | 24 (34.3%) |
Gender | |
Men | 59 (84.3%) |
Women | 11 (15.7%) |
Median performance status (KPS) | 90 |
80% | 25 (35.7%) |
90% | 12 (17.1%) |
100% | 33 (47.1%) |
Histology | |
Squamous cell | 31 (44.3%) |
Adenocarcinoma | 23 (32.9%) |
Large cell Carcinoma | 13 (18.6%) |
Giant cell carcinoma | 3 (4.3%) |
Staging | |
IIIA | 20 (28.6%) |
IIIB | 48 (68.6%) |
IV* | 2 (2.9%) |
Median delay between diagnosis and study entry, months (range) | 1 (0.2-6.4) |